Importantly, leniolisib dose-dependently increased apoptosis as measured by AV/PI staining (Figure 7E) and enhanced caspase 3/7 activity in two of our in vitro LOF models of PAH (Figure E7). Here, CASP3 is linked to pulmonary arterial hypertension.